Article info
PDFTherapeutics
Short report
Rescue of primary ubiquinone deficiency due to a novel COQ7 defect using 2,4–dihydroxybensoic acid
- Correspondence to Dr Anna Wredenberg, Division for Metabolic Diseases, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; anna.wredenberg{at}ki.se, and Prof. Anna Wedell, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; anna.wedell{at}ki.se
Citation
Rescue of primary ubiquinone deficiency due to a novel COQ7 defect using 2,4–dihydroxybensoic acid
Publication history
- Received January 15, 2015
- Revised April 28, 2015
- Accepted May 26, 2015
- First published June 17, 2015.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
- Data supplement 1 - Online supplement
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/